Oral vaccination with recombinant Listeria monocytogenes expressing human papillomavirus type 16 E7 can cause tumor growth in mice to regress

Chih Wei Lin, Jen Yi Lee, Yeou Ping Tsao, Che Piao Shen, Hung Cheng Lai, Show Li Chen

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Listeria monocytogenes is a Gram-positive, facultative intra-cellular bacterium with the ability to present secreted proteins to the major histocompatibility complex class I pathway to stimulate cell-mediated immune response. In our study, we constructed the recombinant L. monocytogenes encoding human papillomavirus type 16 E7 gene (rLM-E7). When orally administered to syngeneic mice, rLM-E7 could induce a cytotoxic T-lymphocyte (CTL) response. Furthermore, in vitro flow cytometric assay and in vivo immune deficiency assays showed that rLM-E7 could prevent and eradicate tumor growth via CD8+-dependent CTLs. Hence, the potency of rLM-E7 as a therapeutic vaccine for cervical cancer is the result of the induction E7-specific cell-mediated immunity by L. monocytogenes. In addition to potency, this vaccine also offers ease of administration and reduced cost of production compared with other vaccines formulated for injection. Thus, L. monocytogenes encoding HPV-16 E7 may be a useful oral vaccine for cervical cancer treatment.

Original languageEnglish
Pages (from-to)629-637
Number of pages9
JournalInternational Journal of Cancer
Volume102
Issue number6
DOIs
Publication statusPublished - Dec 20 2002
Externally publishedYes

Fingerprint

Human papillomavirus 16
Listeria monocytogenes
Vaccination
Vaccines
Growth
Uterine Cervical Neoplasms
Neoplasms
Vaccine Potency
Cytotoxic T-Lymphocytes
Major Histocompatibility Complex
Cellular Immunity
Bacteria
Costs and Cost Analysis
Injections
Therapeutics
Genes
Proteins

Keywords

  • E7
  • HPV-16
  • Listeria
  • Oral vaccine
  • Tumor vaccine

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Oral vaccination with recombinant Listeria monocytogenes expressing human papillomavirus type 16 E7 can cause tumor growth in mice to regress. / Lin, Chih Wei; Lee, Jen Yi; Tsao, Yeou Ping; Shen, Che Piao; Lai, Hung Cheng; Chen, Show Li.

In: International Journal of Cancer, Vol. 102, No. 6, 20.12.2002, p. 629-637.

Research output: Contribution to journalArticle

@article{d50018c8daf6489bab679dde0d8d03e7,
title = "Oral vaccination with recombinant Listeria monocytogenes expressing human papillomavirus type 16 E7 can cause tumor growth in mice to regress",
abstract = "Listeria monocytogenes is a Gram-positive, facultative intra-cellular bacterium with the ability to present secreted proteins to the major histocompatibility complex class I pathway to stimulate cell-mediated immune response. In our study, we constructed the recombinant L. monocytogenes encoding human papillomavirus type 16 E7 gene (rLM-E7). When orally administered to syngeneic mice, rLM-E7 could induce a cytotoxic T-lymphocyte (CTL) response. Furthermore, in vitro flow cytometric assay and in vivo immune deficiency assays showed that rLM-E7 could prevent and eradicate tumor growth via CD8+-dependent CTLs. Hence, the potency of rLM-E7 as a therapeutic vaccine for cervical cancer is the result of the induction E7-specific cell-mediated immunity by L. monocytogenes. In addition to potency, this vaccine also offers ease of administration and reduced cost of production compared with other vaccines formulated for injection. Thus, L. monocytogenes encoding HPV-16 E7 may be a useful oral vaccine for cervical cancer treatment.",
keywords = "E7, HPV-16, Listeria, Oral vaccine, Tumor vaccine",
author = "Lin, {Chih Wei} and Lee, {Jen Yi} and Tsao, {Yeou Ping} and Shen, {Che Piao} and Lai, {Hung Cheng} and Chen, {Show Li}",
year = "2002",
month = "12",
day = "20",
doi = "10.1002/ijc.10759",
language = "English",
volume = "102",
pages = "629--637",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - Oral vaccination with recombinant Listeria monocytogenes expressing human papillomavirus type 16 E7 can cause tumor growth in mice to regress

AU - Lin, Chih Wei

AU - Lee, Jen Yi

AU - Tsao, Yeou Ping

AU - Shen, Che Piao

AU - Lai, Hung Cheng

AU - Chen, Show Li

PY - 2002/12/20

Y1 - 2002/12/20

N2 - Listeria monocytogenes is a Gram-positive, facultative intra-cellular bacterium with the ability to present secreted proteins to the major histocompatibility complex class I pathway to stimulate cell-mediated immune response. In our study, we constructed the recombinant L. monocytogenes encoding human papillomavirus type 16 E7 gene (rLM-E7). When orally administered to syngeneic mice, rLM-E7 could induce a cytotoxic T-lymphocyte (CTL) response. Furthermore, in vitro flow cytometric assay and in vivo immune deficiency assays showed that rLM-E7 could prevent and eradicate tumor growth via CD8+-dependent CTLs. Hence, the potency of rLM-E7 as a therapeutic vaccine for cervical cancer is the result of the induction E7-specific cell-mediated immunity by L. monocytogenes. In addition to potency, this vaccine also offers ease of administration and reduced cost of production compared with other vaccines formulated for injection. Thus, L. monocytogenes encoding HPV-16 E7 may be a useful oral vaccine for cervical cancer treatment.

AB - Listeria monocytogenes is a Gram-positive, facultative intra-cellular bacterium with the ability to present secreted proteins to the major histocompatibility complex class I pathway to stimulate cell-mediated immune response. In our study, we constructed the recombinant L. monocytogenes encoding human papillomavirus type 16 E7 gene (rLM-E7). When orally administered to syngeneic mice, rLM-E7 could induce a cytotoxic T-lymphocyte (CTL) response. Furthermore, in vitro flow cytometric assay and in vivo immune deficiency assays showed that rLM-E7 could prevent and eradicate tumor growth via CD8+-dependent CTLs. Hence, the potency of rLM-E7 as a therapeutic vaccine for cervical cancer is the result of the induction E7-specific cell-mediated immunity by L. monocytogenes. In addition to potency, this vaccine also offers ease of administration and reduced cost of production compared with other vaccines formulated for injection. Thus, L. monocytogenes encoding HPV-16 E7 may be a useful oral vaccine for cervical cancer treatment.

KW - E7

KW - HPV-16

KW - Listeria

KW - Oral vaccine

KW - Tumor vaccine

UR - http://www.scopus.com/inward/record.url?scp=0037146759&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037146759&partnerID=8YFLogxK

U2 - 10.1002/ijc.10759

DO - 10.1002/ijc.10759

M3 - Article

VL - 102

SP - 629

EP - 637

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 6

ER -